Skip to main content
$10.39 -$0.21 (-2.0%)

02:32 PM EST on 12/02/20

Innoviva Inc. (NASDAQ:INVA)

CAPS Rating: 5 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

Current Price $10.39 Mkt Cap $1.1B
Open $10.61 P/E Ratio 4.96
Prev. Close $10.60 Div. (Yield) $0.00 (0.0%)
Daily Range $10.36 - $10.68 Volume 155,576
52-Wk Range $7.58 - $15.62 Avg. Daily Vol. 710,608

Caps

How do you think NASDAQ:INVA will perform against the market?

Add Stock to CAPS Watchlist

All Players

102 Outperform
29 Underperform
 

All-Star Players

18 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:INVA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFSaintCroix (99.82)
Submitted January 14, 2018

Just started researching this stock. The numbers are kind of insane!p.e. (trailing) 17p.e. (forward) 7PEG 0.27profit margin 52%and the growth is fantasticcurrent year 103%next year 79%next five years 49%and on top of all this, 65% of shares are sold… More

zzlangerhans (97.59)
Submitted September 25, 2010

The recent bull charge has carried several baby biotechs and small pharmas out of their trading range without positive catalysts, which primes them for disproportionate drops as soon as the momentum inevitably shifts. Theravance has been bouncing… More

NASDAQ:INVA VS S&P 500 (SPY)

Fools bullish on NASDAQ:INVA are also bullish on:

Fools bearish on NASDAQ:INVA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about INVA.

Recs

0
Member Avatar TMFacarchidi (39.82) Submitted: 8/6/2020 3:42:12 PM : Outperform Start Price: $13.33 NASDAQ:INVA Score: -31.38

High profit margin, low price to book ratio, and rising revenues, all without any need for physical manufacturing assets or R&D expenditure.

Recs

0
Member Avatar healthcarevalue (69.31) Submitted: 5/28/2020 5:10:10 PM : Outperform Start Price: $14.75 NASDAQ:INVA Score: -50.54

Market cap 1.455 billion. Price earnings 8.63. Return on Invested Capital of 29.92. Debt equity of 1.00.

Recs

0
Member Avatar BernieRosa (67.96) Submitted: 1/8/2019 7:23:36 PM : Outperform Start Price: $19.00 NASDAQ:INVA Score: -87.21

Grow and more Grow!

Leaderboard

Find the members with the highest scoring picks in INVA.

Score Leader

Evad005

Evad005 (< 20) Score: +369.93

The Score Leader is the player with the highest score across all their picks in INVA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Evad005 < 20 3/25/2009 Underperform 3M $12.24 -14.99% +354.94% +369.93 0 Comment
jmacn22 30.89 2/5/2009 Underperform 3Y $11.97 -13.00% +339.03% +352.03 1 Comment
anticitradeshort 30.92 4/20/2009 Underperform NS $10.36 +0.47% +332.02% +331.55 0 Comment
qubit15 24.96 1/21/2009 Underperform NS $8.07 +29.07% +356.97% +327.90 0 Comment
schwah4 28.02 12/29/2008 Underperform NS $8.23 +26.54% +334.26% +307.73 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $10.31 +0.98% +251.23% +250.26 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $10.31 +0.98% +251.23% +250.26 0 Comment
haimp 26.63 10/7/2010 Underperform 5Y $15.87 -34.39% +215.70% +250.09 0 Comment
alexdowns77 32.73 10/1/2010 Underperform 5Y $14.54 -28.41% +219.87% +248.28 0 Comment
withoutlimits 85.18 10/1/2010 Underperform 5Y $14.84 -29.86% +218.06% +247.92 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for INVA.